Page 93 - Hospital Authority Annual Report 2019-2020
P. 93

NOTES TO THE FINANCIAL                                     財務報表附註
               STATEMENTS



               10.  Fixed income instruments                              10.  固定入息工具

                    The fixed income instruments represent Hong Kong dollar      固定入息工具是指由購買日期起計五年內到
                    certificates of deposits and bonds with maturity periods within   期的港元存款證及債券,在報告日的投資收
                    five years from the date of purchase. The investment yields at the   益介乎2.63% 至3.18% 之間(二零一九年:
                    reporting date were between 2.63% and 3.18% (2019: between 3.05%   在3.05% 至3.18% 之間)。
                    and 3.18%).

                    At 31 March 2020, the fixed income instruments held by the Group      於二零二零年三月三十一日,集團及醫管局
                    and HA are as follows:                                     持有的固定入息工具如下:

                     The Group and HA 集團及醫管局

                                                                              At 31 March 2020    At 31 March 2019
                                                                                     HK$’000             HK$’000
                                                                               2020年3月31日         2019年3月31日
                                                                                     港幣千元               港幣千元

                    Maturing within one year 一年內到期                                  1,899,257                 -
                    Maturing between one and five years 一至五年內到期                            -             799,552
                                                                                    1,899,257            799,552



                    The above financial assets are neither past due nor impaired. The      上述金融資產並沒有逾期或減值,這些資
                    credit quality of these assets is disclosed in note 3(a) while the   產的信貸質素披露於附註3(a)。在報告日,
                    maximum exposure to credit risk at the reporting date is the fair   最大的信貸風險是附註3(b)(ii)所列這些資
                    value of these assets as stated in note 3(b)(ii). The Group does not   產的公允價值。集團並未持有任何抵押品作
                    hold any collateral as security.                           抵押。


               11.  Inventories                                           11.  存貨


                     The Group and HA 集團及醫管局

                                                                              At 31 March 2020    At 31 March 2019
                                                                                     HK$’000             HK$’000
                                                                               2020年3月31日         2019年3月31日
                                                                                     港幣千元               港幣千元
                    Drugs 藥物                                                        1,409,632           1,157,659
                    Medical consumables 醫療消耗品                                         285,583            199,554
                    General consumables 一般消耗品                                         19,527              20,104
                                                                                    1,714,742           1,377,317






















                                        Independent Auditor’s Report and Audited Financial Statements  獨立核數師報告及經審核的財務報表  91
   88   89   90   91   92   93   94   95   96   97   98